Published in Anticancer Res on September 20, 1999
Synergistic effects of 15-deoxy Δ(12,14)-prostaglandin J2 on the anti-tumor activity of doxorubicin in renal cell carcinoma. Biochem Biophys Rep (2016) 0.75
Acute generalized exanthematous pustulosis. Analysis of 63 cases. Arch Dermatol (1991) 3.29
Lon-dependent proteolysis of CcdA is the key control for activation of CcdB in plasmid-free segregant bacteria. Mol Microbiol (1994) 2.02
[Survey of post-graduate training for Dermatology and Venereology residents in France (2005-2010)]. Ann Dermatol Venereol (2013) 2.00
Who benefits from immunotherapy? Allergy (1997) 1.97
Risk factors for erysipelas of the leg (cellulitis): case-control study. BMJ (1999) 1.79
The EPISA study: antimicrobial susceptibility of Staphylococcus aureus causing primary or secondary skin and soft tissue infections in the community in France, the UK and Ireland. J Antimicrob Chemother (2008) 1.75
Evaluation of clinical criteria for diagnosis of bullous pemphigoid. French Bullous Study Group. Arch Dermatol (1998) 1.70
[Malignant ethmoid bone tumors in woodworkers]. J Med Lyon (1969) 1.68
Calcifying fibrous pseudotumour: first case report in the peritoneum with immunostaining for CD34. Histopathology (1999) 1.63
From adaptive licensing to adaptive pathways: delivering a flexible life-span approach to bring new drugs to patients. Clin Pharmacol Ther (2015) 1.59
Kinetics of gentamicin uptake and release in the rat. Comparison of inner ear tissues and fluids with other organs. J Clin Invest (1986) 1.57
Controlled trial of azathioprine and plasma exchange in addition to prednisolone in the treatment of bullous pemphigoid. Arch Dermatol (1993) 1.52
Study of the apoptosis induced in vitro by antitumoral drugs on leukaemic cells. Leuk Res (1997) 1.50
Clinical and histological features of head and neck melanoma: a population-based study in France. Br J Dermatol (2015) 1.42
Role of drug exposure in aphthous ulcers: a case-control study. Br J Dermatol (2000) 1.39
The role of general practitioners in diagnosis of cutaneous melanoma: a population-based study in France. Br J Dermatol (2012) 1.39
[Haemorrhagic cellulitis: three cases]. Ann Dermatol Venereol (2003) 1.38
Cloxacillin versus pristinamycin for superficial pyodermas: a randomized, open-label, non-inferiority study. Dermatology (2005) 1.38
Flow cytometry CD45 gating for immunophenotyping of acute myeloid leukemia. Leukemia (1997) 1.36
Modalities of synthesis of Ki67 antigen during the stimulation of lymphocytes. Cytometry (1991) 1.29
A flow cytometric method using Hoechst 33342 and propidium iodide for simultaneous cell cycle analysis and apoptosis determination in unfixed cells. Cytometry (1994) 1.28
The activation of human endogenous retrovirus K (HERV-K) is implicated in melanoma cell malignant transformation. Exp Cell Res (2009) 1.27
CPP, a selective N-methyl-D-aspartate (NMDA)-type receptor antagonist: characterization in vitro and in vivo. J Pharmacol Exp Ther (1987) 1.24
Intermediate clinical and radiological results of cervical TDR (Mobi-C) with up to 2 years of follow-up. Eur Spine J (2009) 1.23
Drugs associated with bullous pemphigoid. A case-control study. Arch Dermatol (1996) 1.23
Sclerotherapy with or without octreotide for acute variceal bleeding. N Engl J Med (1995) 1.21
Analytical methods for thromboxane B2 measurement and validation of radioimmunoassay by gas liquid chromatography-mass spectrometry. Prostaglandins (1978) 1.21
Lactose and milk intolerance: clinical implications. N Engl J Med (1975) 1.21
Scorpion toxins: chemistry and mode of action. Adv Cytopharmacol (1979) 1.20
Comparison between single- and multi-level patients: clinical and radiological outcomes 2 years after cervical disc replacement. Eur Spine J (2011) 1.18
Implication of interleukin-4 in wound healing. Lab Invest (2000) 1.15
Preliminary screening of some tropical plants for anti-tyrosinase activity. J Ethnopharmacol (2002) 1.14
The antidote and autoregulatory functions of the F plasmid CcdA protein: a genetic and biochemical survey. Mol Gen Genet (1994) 1.13
The early clinical course of primary Ta and T1 bladder cancer: a proposed prognostic index. Br J Urol (1998) 1.13
Intrasinusoidal bone marrow involvement by splenic lymphoma with villous lymphocytes: a helpful immunohistologic feature. Mod Pathol (1997) 1.13
F plasmid CcdB killer protein: ccdB gene mutants coding for non-cytotoxic proteins which retain their regulatory functions. Mol Microbiol (1995) 1.12
Redox pathway leading to the alkylation of DNA by the anthracycline, antitumor drugs adriamycin and daunomycin. J Med Chem (1997) 1.12
High risk of death in elderly patients with extensive bullous pemphigoid. Arch Dermatol (1998) 1.08
Daily variations of protein intake in haemodialysed patients. Nephrol Dial Transplant (1998) 1.07
Various effects of antidepressant drugs on bone microarchitectecture, mechanical properties and bone remodeling. Toxicol Appl Pharmacol (2007) 1.07
Late lethal hepatitis B virus reactivation after rituximab treatment of low-grade cutaneous B-cell lymphoma. Br J Dermatol (2006) 1.07
Regulation of nitrogen metabolism is altered in a glnB mutant strain of Rhizobium leguminosarum. Mol Microbiol (1994) 1.05
The biosynthesis of the macrolide antibiotic lucensomycin. J Antibiot (Tokyo) (1969) 1.05
Cicatricial pemphigoid autoantibodies react with multiple sites on the BP180 extracellular domain. J Invest Dermatol (1996) 1.04
Fusion of a novel gene, BTL, to ETV6 in acute myeloid leukemias with a t(4;12)(q11-q12;p13). Blood (1999) 1.04
Prenatal diagnosis of isolated total anomalous systemic venous return to the coronary sinus. Ultrasound Obstet Gynecol (2010) 1.04
Alkylation of DNA by the anthracycline, antitumor drugs adriamycin and daunomycin. J Med Chem (1996) 1.02
Prenatal diagnosis of human cytomegalovirus by culture and polymerase chain reaction: 98 pregnancies leading to congenital infection. Prenat Diagn (1999) 1.01
D-dimer strategy in thrombosis exclusion--a gold standard study in 100 patients suspected of deep venous thrombosis or pulmonary embolism: 8 DD methods compared. Thromb Haemost (1998) 1.01
How to recognize and workaround pitfalls in QSAR studies: a critical review. Curr Med Chem (2009) 1.01
Determinants of persistent detection of human papillomavirus DNA in the uterine cervix. J Infect Dis (1996) 1.01
Cumulative influence of matrix metalloproteinase-1 and -2 in the migration of melanoma cells within three-dimensional type I collagen lattices. Exp Cell Res (2001) 0.99
Bullous pemphigoid and cicatricial pemphigoid autoantibodies react with ultrastructurally separable epitopes on the BP180 ectodomain: evidence that BP180 spans the lamina lucida. J Invest Dermatol (1997) 0.99
Congenital solitary histiocytoma: a variant of Hashimoto-Pritzker histiocytosis. A retrospective study of 8 cases. Dermatology (2008) 0.98
Methodology for development of the Allergic Rhinitis and its Impact on Asthma guideline 2008 update. Allergy (2008) 0.97
Nerve growth factor: neurotrophin or cytokine? Int Arch Allergy Immunol (2003) 0.96
Expression of REG protein during cell growth and differentiation of two human colon carcinoma cell lines. J Histochem Cytochem (1999) 0.96
[Post-traumatic acral melanoma: an underestimated reality?]. Ann Dermatol Venereol (2012) 0.96
[Dermatitis artefacta: retrospective study in 31 patients]. Ann Dermatol Venereol (2006) 0.96
p53 and c-erbB-2 as markers of resistance to adjuvant chemotherapy in breast cancer. Mod Pathol (1998) 0.96
Anti-inflammatory drugs and variceal bleeding: a case-control study. Gut (1999) 0.96
[Goldmann-Favre hyaloido-tapeto-retinal degeneration. Apropos of a case]. Bull Mem Soc Fr Ophtalmol (1973) 0.95
Thymosin alpha 1 in the treatment of cancer: from basic research to clinical application. Int J Immunopharmacol (2000) 0.95
Production of formaldehyde and DNA-adriamycin or DNA-daunomycin adducts, initiated through redox chemistry of dithiothreitol/iron, xanthine oxidase/NADH/iron, or glutathione/iron. Chem Res Toxicol (1997) 0.95
Early transitory rise in intracellular pH leads to Bax conformation change during ceramide-induced apoptosis. Apoptosis (2000) 0.95
Successful autologous transplantation with peripheral blood hemopoietic cells in a patient with acute leukemia. Exp Hematol (1986) 0.94
Prognostic significance of karyotype in de novo adult acute myeloid leukemia. The BGMT group. Leukemia (1995) 0.94
Response at three months is a good predictive factor for newly diagnosed chronic myeloid leukemia patients treated by recombinant interferon-alpha. Blood (1998) 0.93
Adjuvant prophylactic regional radiotherapy versus observation in stage I Merkel cell carcinoma: a multicentric prospective randomized study. Ann Oncol (2011) 0.92
Time to market and patient access to new oncology products in Italy: a multistep pathway from European context to regional health care providers. Ann Oncol (2010) 0.92
Automated reticulocyte counting and immature reticulocyte fraction measurement. Comparison of ABX PENTRA 120 Retic, Sysmex R-2000, flow cytometry, and manual counts. Am J Clin Pathol (1999) 0.92
Autologous peripheral-blood progenitor-cell support following high-dosechemotherapy or chemoradiotherapy in patients with high-risk multiple myeloma. J Clin Oncol (1996) 0.92
Preaortic paraganglioma mimicking a hypervascular tumor of the pancreas. Hepatogastroenterology (2004) 0.91
[Ischemic colitic in the elderly: predictive factors of gangrenous outcome]. Gastroenterol Clin Biol (1999) 0.91
Defects in components of the proteasome enhance transcriptional silencing at fission yeast centromeres and impair chromosome segregation. Mol Cell Biol (1999) 0.90
Caspase activation is an early event in anthracycline-induced apoptosis and allows detection of apoptotic cells before they are ingested by phagocytes. Exp Cell Res (1998) 0.90
Anticytomegalovirus IgG avidity in pregnancy: a 2-year prospective study. Fetal Diagn Ther (2002) 0.90
[Acute generalized exanthematous pustulosis in hypercalcemia]. Ann Dermatol Venereol (2000) 0.89
Bullous pemphigoid in association with cutaneous lesions specific to a myelodysplastic syndrome. Br J Dermatol (1997) 0.89
Uridylylation of the PII protein in Rhizobium leguminosarum. FEBS Lett (1993) 0.89
Paraneoplastic pemphigus in a child with a T-cell lymphoblastic lymphoma. Br J Dermatol (1993) 0.89
Prevalence and clinical significance of HER/2neu, p53 and Rb expression in primary superficial bladder cancer. J Urol (1996) 0.89
[Hepatitis during treatment with tienilic acid (author's transl)]. Therapie (1980) 0.89
Microfabricated biocapsules provide short-term immunoisolation of insulinoma xenografts. Biomed Microdevices (1999) 0.89
Psychological effect of exercise in women with breast cancer receiving adjuvant therapy: what is the optimal dose needed? Ann Oncol (2012) 0.89
Functional characterization of liver-associated lymphocytes in patients with liver metastasis. Gastroenterology (1993) 0.89
[Vulvar involvement in Crohn's disease: efficacy of metronidazole]. Ann Dermatol Venereol (2006) 0.89
CXCL10 reduces melanoma proliferation and invasiveness in vitro and in vivo. Br J Dermatol (2011) 0.88
Respective contribution of neutrophil elastase and matrix metalloproteinase 9 in the degradation of BP180 (type XVII collagen) in human bullous pemphigoid. J Invest Dermatol (2001) 0.88
Effect of whole-body gamma irradiation on lipid peroxidation in rat tissues. Biochimie (1981) 0.88
Purification, circular dichroism analysis, crystallization and preliminary X-ray diffraction analysis of the F plasmid CcdB killer protein. J Mol Biol (1993) 0.88
Added value of diffusion weighted MR imaging in the diagnosis of postpartum ovarian vein thrombosis. JBR-BTR (2015) 0.88
Rat olfactory bulb and epithelium UDP-glucuronosyltransferase 2A1 (UGT2A1) expression: in situ mRNA localization and quantitative analysis. Brain Res Mol Brain Res (2001) 0.87
Evaluation of four methods of DNA distribution data analysis based on bromodeoxyuridine/DNA bivariate data. Cytometry (1988) 0.86
Tumor-associated antigens as prognostic factors for recurrence in 382 patients with primary transitional cell carcinoma of the bladder. Clin Cancer Res (1995) 0.86
Reverse pharmacognosy: another way to harness the generosity of nature. Curr Pharm Des (2010) 0.86
Localized pretibial pemphigoid and pemphigoid nodularis. J Am Acad Dermatol (1992) 0.86